Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year debt growth rate
5Y CAGR
+50.4%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
7.7x
Strong expansion
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 6.84% |
| Q3 2025 | -32.64% |
| Q2 2025 | -0.79% |
| Q1 2025 | -0.37% |
| Q4 2024 | -0.86% |
| Q3 2024 | -0.64% |
| Q2 2024 | 11.49% |
| Q1 2024 | -0.73% |
| Q4 2023 | -0.72% |
| Q3 2023 | -4.90% |
| Q2 2023 | -0.71% |
| Q1 2023 | -18.11% |
| Q4 2022 | -7.09% |
| Q3 2022 | -1.17% |
| Q2 2022 | -16.96% |
| Q1 2022 | -11.31% |
| Q4 2021 | 103.56% |
| Q3 2021 | 0.96% |
| Q2 2021 | 0.94% |
| Q1 2021 | 0.56% |
| Q4 2020 | 0.89% |
| Q3 2020 | 35.55% |
| Q2 2020 | 11.70% |
| Q1 2020 | 0.66% |
| Q4 2019 | 1.71% |
| Q3 2019 | 0.76% |
| Q2 2019 | 4.30% |
| Q1 2019 | 13.17% |
| Q4 2018 | 1.29% |
| Q3 2018 | 1.28% |
| Q2 2018 | 1.28% |
| Q1 2018 | 1.27% |
| Q4 2017 | 1.27% |
| Q3 2017 | 1.26% |
| Q2 2017 | 1.09% |
| Q1 2017 | 145.32% |
| Q4 2016 | 1.09% |
| Q3 2016 | 1.10% |
| Q2 2016 | 1.11% |
| Q1 2016 | -0.67% |